NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
- Update frequency
- every 3 days
- Episodes
- 369
- Years Active
- 2008 - 2025
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challen…
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Guest: B. Joy Snider, MD, PhD
Guest: Charles P. Vega, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managemen…
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), …
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challen…
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Guest: Charles P. Vega, MD
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managemen…
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Amyloid-related imaging abnormalities (ARIA) represent a critical challen…
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), r…
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challe…
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
While multiple kinds of animal models are commonly used to study multiple sclerosis (MS), they are not always ideal for getting the full picture of the dis…
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
While multiple kinds of animal models are commonly used to study multiple sclerosis (MS), they are not always ideal for getting the full picture of the dis…
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
A recent study examined the association between comorbidities, adverse events, and early trial discontinuation in phase III clinical trials for disease-modifying th…
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
A recent study examined the association between comorbidities, adverse events, and early trial discontinuation in phase III clinical trials for disease-modifying th…
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
A recent study found that a ketogenic diet may have anti-inflammatory effects in patients with multiple sclerosis (MS), potentially reducing relapse risk. H…
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
A recent study found that a ketogenic diet may have anti-inflammatory effects in patients with multiple sclerosis (MS), potentially reducing relapse risk. H…
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
To address the concerning effects of demyelinating events in patients with multiple sclerosis (MS), a recent study explored whether neuromodulation could support m…
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Prodromal symptoms are common in neurologic and inflammatory conditions like multiple sclerosis (MS). Recent evidence suggests that prodromal symptoms also ex…